Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2009-07-23

Clinical Trial Update: Effects of Cox-II Inhibitor on Biochemical Markers in Cardiovascular-related Adverse Effects

View source ↗

Summary

Clinical trial update examining COX-2 inhibitor effects on biochemical markers related to cardiovascular adverse effects in arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cox-II Inhibitor (COX-2 inhibitor)

Snippet

Sponsor: National Chung Hsing University | Conditions: Arthritis | Status: UNKNOWN